In this Summit you will learn more about doing partnership and commercialize CDx tests with pharmaceutical and biotech companies. We will also provide solutions to assist in all stages of CDx development from the biomarker discovery process through CDx commercialization.
The BioTech Pharma Summit: AI Pharma 2018 will showcase the real world application and impact of AI, machine learning, deep learning and cognitive approaches to unlock insight and value along the drug discovery and development pipeline to deliver better medicines with better outcomes.
With the global Orphan Drug market expected to grow to $127 billion by 2018-2019, and another Rare Disease Day just having passed, there is a constantly growing awareness and interest for this industry, enabling more research to make a difference in patients’ lives.
The BioTech Pharma Summit: Liquid Biopsy 2018 focuses primarily on biofluid-based molecular biomarkers, such as circulating tumor DNA (ctDNA) as well as circulating tumor cells (CTCs), and protein-based circulating biomarkers.
In the era of precision medicine, enormous amounts of data are being generated from disparate sources, including omics, imaging, sensing and beyond. Today, computational scientists need to develop better tools to manage, integrate and share data to make it clinically actionable.
Precision Medicine & Biomarkers 2018 will be focused on the opportunities and challenges of biomarker research discovery and development in a variety of therapeutic areas such as immune-oncology, neuroscience and cardio vascular disease areas, precision medicine, companion diagnostics, data integration methods, and utilising biomarkers in clinical trials.